Prothena Corp PLC
(NAS:PRTA)
$
21.44
1.82 (9.26%)
Market Cap: 1.15 Bil
Enterprise Value: 618.85 Mil
PE Ratio: 0
PB Ratio: 2.29
GF Score: 68/100 Prothena Corp PLC (PRTA) Transcripts
- Q4 2023 Prothena Corporation PLC Earnings Call TranscriptFeb 15, 2024$28.52 (+4.51%)Earnings
- Prothena Corporation PLC at Morgan Stanley Global Healthcare Conference TranscriptSep 11, 2023
- Prothena Corporation PLC at Jefferies Healthcare Conference TranscriptJun 08, 2023
- Prothena Corporation PLC at Bank of America Global Healthcare Conference TranscriptMay 09, 2023
- Prothena Corporation PLC at Stifel CNS Days (Virtual) TranscriptMar 28, 2023
- Q4 2022 Prothena Corporation PLC Earnings Call TranscriptFeb 23, 2023$50.9 (-2.30%)Earnings
- Prothena Corporation PLC at Morgan Stanley Global Healthcare Conference TranscriptSep 13, 2022
- Prothena Corporation PLC at Bank of America Healthcare Conference TranscriptMay 10, 2022
- Prothena Corporation PLC at Stifel CNS Days (Virtual) TranscriptMar 28, 2022
- Q4 2021 Prothena Corporation PLC Earnings Call TranscriptFeb 17, 2022$35.06 (-5.90%)Earnings
- Prothena Corporation PLC at Cantor Fitzgerald Global Healthcare Conference (Virtual) TranscriptSep 27, 2021
- Prothena Corporation PLC at Citi BioPharma Conference (Virtual) - Fireside Chat TranscriptSep 08, 2021
- Prothena Corporation PLC at RBC Capital Markets Global Healthcare Conference (Virtual) TranscriptMay 19, 2021
- Prothena Corporation PLC to Review Oral Presentations from AD/PD 2021 TranscriptMar 11, 2021
- Q4 2020 Prothena Corporation PLC Earnings Call TranscriptFeb 11, 2021$15.7 (-0.19%)Earnings
- Prothena Corporation PLC to Discuss AFFIRM-AL Study - Conference Call TranscriptFeb 02, 2021
- Prothena Corporation PLC - PRX004 Phase 1 Study Results TranscriptDec 09, 2020
- Prothena Corporation PLC to Discuss Results from Part 1 of the Phase 2 PASADENA Study - Conference Call TranscriptSep 15, 2020
- Q4 2019 Prothena Corporation PLC Earnings Call TranscriptFeb 12, 2020$13.51 (+4.49%)Earnings
- Prothena Corporation PLC to Discuss Results of the Phase 3 VITAL Amyloidosis Study - Conference Call TranscriptApr 18, 2019
- Prothena Corporation PLC at Barclays Global Healthcare Conference TranscriptMar 12, 2019
- Q4 2018 Prothena Corporation PLC Earnings Call TranscriptFeb 14, 2019$12.75Earnings
- 1